Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Menactra and Tdap in Adolescents
NCT00777257Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Mar 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of meningococcal A conjugate vaccine in meningococcal meningitis, meningococcemia, Tetanus and 2 more (3 arms), sponsored by Sanofi. Primary endpoints: Percentage of Participants With at Least a 4-fold Rise in Meningococcal Antibody Titer at Day 28, Geometric Mean Concentrations of Diphtheria and Tetanus Antibodies at Day 28 and 1 more. Started Apr 2005; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitismeningococcemiaTetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00777257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777257.